XML 38 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Note 10 - Government Assistance
6 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Government Assistance [Text Block]

10.

Government assistance:

 

Government assistance is comprised of a government grant from the Canadian federal government and research and development investment tax credits receivable from the Québec provincial government, which relate to qualifiable research and development expenditures under the applicable tax laws. The amounts recorded as receivables are subject to a government tax audit and the final amounts received may differ from those recorded. For the six-month periods ended September 30, 2021, and September 30, 2020, the Corporation recorded $129 and $84, respectively, as a reduction of research and development expenses in the Statement of Loss and Comprehensive Loss.

 

In September 2019, the Corporation was awarded up to CAD $750 in non-dilutive and non-repayable funding from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) to apply towards eligible research and development disbursements of the Corporation’s unique commercial production platform for CaPre. In October 2020, the Corporation received correspondence from the NRC IRAP that the eligible amount awarded to the Corporation for non-dilutive and non-repayable funding was reduced from up to CAD $750 to up to CAD $326. During the six-month period ended September 30, 2021, and September 30, 2020, the Corporation claimed nil and $79, respectively, in connection with this program, which has been recorded as a reduction of research and development expenses in the Consolidated Statements of Loss and Comprehensive Loss.